Evidence map›Paper›PMID 32217457›Full record

GuidelineBreast (Edinburgh, Scotland)2020

The requirements of a specialist breast centre.

Laura Biganzoli, Fatima Cardoso, Marc Beishon, David Cameron, Luigi Cataliotti, Charlotte E Coles, Roberto C Delgado Bolton, Maria Die Trill, Sema Erdem, Maria Fjell and 17 more

Abstract readPractice Guideline
In one paragraph

Guideline in Breast (Edinburgh, Scotland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 102 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
102citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

102 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Guideline
  2. Pooled it
  3. Guideline
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

42 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Laura BiganzoliEuropean Society of Breast Cancer Specialists (EUSOMA); Breast Centre, AUSL Toscana Centro, Prato, Italy. Electronic address: laura.biganzoli@uslcentro.toscana.it.
Fatima CardosoEuropean Society of Medical Oncology (ESMO); Breast Unit, Champalimaud Clinical Center-Champalimaud Foundation, Lisbon, Portugal.
Marc BeishonEuropean School of Oncology (ESO), Milan, Italy.
David CameronEuropean Cancer Concord (ECC); University of Edinburgh Cancer Centre, IGMM, Western General Hospital, Edinburgh, UK.
Luigi CataliottiEuropean Society of Breast Cancer Specialists (EUSOMA), Senonetwork Italia and Breast Centres Certification, Florence, Italy.
Charlotte E ColesEuropean Society for Radiotherapy and Oncology (ESTRO); University of Cambridge, Cambridge, UK.
Roberto C Delgado BoltonEuropean Association of Nuclear Medicine (EANM); Department of Diagnostic Imaging (Radiology) and Nuclear Medicine, University Hospital San Pedro and Centre for Biomedical Research of La Rioja (CIBIR), University of La Rioja, Logroño, La Rioja, Spain.
Maria Die TrillInternational Psycho-Oncology Society (IPOS); ATRIUM: Psycho-Oncology & Clinical Psychology, Madrid, Spain.
Sema ErdemEuropean Cancer Organisation Patient Advisory Committee (ECCO PAC); Europa Donna, Milan, Italy.
Maria FjellEuropean Oncology Nursing Society (EONS); Department of Neurobiology, Care Sciences and Society, Division of Nursing, Karolinska Institutet, Stockholm, Sweden.
Romain GeissInternational Society of Geriatric Oncology (SIOG); Medical Oncology, Hôpital René Huguenin - Institut Curie, St. Cloud, France.
Mathijs GoossensEuropean Cancer League (ECL); Centre for Cancer Detection (CvKO), Brussels, Belgium.
Christiane KuhlEuropean Society of Radiology (ESR); Department of Diagnostic and Interventional Radiology, University Hospital Aachen, Aachen, Germany.
Lorenza MarottiEuropean Society of Breast Cancer Specialists (EUSOMA), Florence, Italy.
Peter NarediEuropean Cancer Organisation (ECCO); Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Simon OberstOrganisation of European Cancer Institutes (OECI); Cancer Research UK Cambridge Centre, Cambridge, UK.
Jean PalussièreCardiovascular and Interventional Radiological Society of Europe (CIRSE); Department of Imaging, Institut Bergonié, Bordeaux, France.
Antonio PontiEuropean Society of Breast Cancer Specialists (EUSOMA), Centre for Epidemiology and Prevention in Oncology (CPO) Piemonte, AOU Citta' Della Salute e Della Scienza, Turin, Italy.
Marco Rosselli Del TurcoEuropean Society of Breast Cancer Specialists (EUSOMA), Radiology, Rome, Italy.
Isabel T RubioEuropean Society of Surgical Oncology (ESSO); Breast Surgical Oncology, Clinica Universidad de Navarra Madrid, Spain.
Anna SapinoEuropean Society of Pathology (ESP); Department of Medical Sciences, University of Turin, Turin, Italy; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Turin, Italy.
Elzbieta Senkus-KonefkaEuropean Organisation for Research and Treatment of Cancer (EORTC); Department of Oncology and Radiotherapy, Medical University of Gdańsk, Gdańsk, Poland.
Marko SkelinEuropean Society of Oncology Pharmacy (ESOP); Pharmacy Department, General Hospital Sibenik, Sibenik, Croatia.
Berta SousaEuropean Society of Oncology Pharmacy (ESOP); Pharmacy Department, General Hospital Sibenik, Sibenik, Croatia.
Tiina SaartoFlims Alumni Club (FAC); Breast Unit, Champalimaud Clinical Center-Champalimaud Foundation, Lisbon, Portugal.
Alberto CostaEuropean School of Oncology (ESO), Milan, Italy.
Philip PoortmansIridium Kankernetwerk, University of Antwerp, Faculty of Medicine and Health Sciences, Campus Drie Eiken, Wilrijk-Antwerp, Belgium.

Funding

Department of Health NIHR300024
6 · The paper itself

Abstract

This article is an update of the requirements of a specialist breast centre, produced by EUSOMA and endorsed by ECCO as part of Essential Requirements for Quality Cancer Care (ERQCC) programme, and ESMO. To meet aspirations for comprehensive cancer control, healthcare organisations must consider the requirements in this article, paying particular attention to multidisciplinarity and patient-centred pathways from diagnosis, to treatment, to survivorship.

Indexed as

Breast NeoplasmsBreast Neoplasms, MaleCancer Care FacilitiesHealth Facility AdministrationQuality of Health CareEuropeFemaleHumansMale

Identifiers

PMID32217457
PMCPMC7375681

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.